To determine whether the SDF-1/CXCR4 pathway is similarly dysregulated in human CKD, we examined gene expression of both receptor and ligand in biopsies from patients with secondary focal segmental glomerulosclerosis (FSGS) and time zero live kidney donor controls. Here, CXCL12 is linked to chronic kidney disease.